美国 · SEC FORM 4
Lantheus Holdings, Inc.
LNTH · Nasdaq · CIK 0001521036 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
0 sales · 14 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2021-03-05 · Maeusli Heinz Christoph.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,783,610
- 上期报告
- 4,036,832
- 日均成交量
- 1,049,857
- 回补天数
- 3.6
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2021-03-05 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 18.60 | USD 18,600 | SEC 申报 ↗ |
| 2021-02-26 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 18.02 | USD 18,020 | SEC 申报 ↗ |
| 2021-02-19 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 19.39 | USD 19,390 | SEC 申报 ↗ |
| 2021-02-12 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 20.03 | USD 20,030 | SEC 申报 ↗ |
| 2021-02-05 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 17.94 | USD 17,940 | SEC 申报 ↗ |
| 2021-01-29 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 16.13 | USD 16,130 | SEC 申报 ↗ |
| 2021-01-22 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 15.29 | USD 15,290 | SEC 申报 ↗ |
| 2021-01-15 | Maeusli Heinz Christoph | 买入 (P) | Common Stock | 1,000 | USD 15.80 | USD 15,800 | SEC 申报 ↗ |
Form 4 申报证据
34 transaction lines in the latest 365-day window; 485 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Marshall Robert J. Jr. | 代扣税 (F) | Common Stock | 721 | USD 100.96 | USD 72,792 | SEC 申报 ↗ |
| 2026-08-17 | Dinkelborg Ludger | 代扣税 (F) | Common Stock | 2,536 | USD 100.91 | USD 255,908 | SEC 申报 ↗ |
| 2026-08-17 | Brown Kimberly | 代扣税 (F) | Common Stock | 463 | USD 100.91 | USD 46,721 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Marshall Robert J. Jr. | 代扣税 (F) | Common Stock | 721 | USD 100.96 | USD 72,792 | SEC 申报 ↗ |
| 2026-08-17 | Dinkelborg Ludger | 代扣税 (F) | Common Stock | 2,536 | USD 100.91 | USD 255,908 | SEC 申报 ↗ |
| 2026-08-17 | Brown Kimberly | 代扣税 (F) | Common Stock | 463 | USD 100.91 | USD 46,721 | SEC 申报 ↗ |
| 2026-05-14 | Heino Mary Anne | 代扣税 (F) | Common Stock | 1,227 | USD 96.67 | USD 118,614 | SEC 申报 ↗ |
| 2026-05-14 | Ber Gerard | 代扣税 (F) | Common Stock | 381 | USD 96.67 | USD 36,831 | SEC 申报 ↗ |
| 2026-05-14 | Thrall James H | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Pruden Gary J | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Morrow Phuong Khanh | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | McHugh Julie | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Maeusli Heinz Christoph | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | LENO SAM R | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | EASTLAND JULIA MARIE | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Ber Gerard | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Baylor-Henry Minnie | 奖励/授予 (A) | Common Stock | 4,137 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-17 | Niedzwiecki Daniel | 代扣税 (F) | Common Stock | 1,911 | USD 83.82 | USD 160,180 | SEC 申报 ↗ |
| 2026-03-05 | Niedzwiecki Daniel | 代扣税 (F) | Common Stock | 1,283 | USD 76.31 | USD 97,906 | SEC 申报 ↗ |
| 2026-03-05 | Niedzwiecki Daniel | 奖励/授予 (A) | Common Stock | 36,692 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Morgan Amanda Michelle | 代扣税 (F) | Common Stock | 595 | USD 76.31 | USD 45,404 | SEC 申报 ↗ |
| 2026-03-05 | Morgan Amanda Michelle | 奖励/授予 (A) | Common Stock | 26,208 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Marshall Robert J. Jr. | 代扣税 (F) | Common Stock | 1,182 | USD 76.31 | USD 90,198 | SEC 申报 ↗ |
| 2026-03-05 | Marshall Robert J. Jr. | 奖励/授予 (A) | Common Stock | 38,002 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Dinkelborg Ludger | 奖励/授予 (A) | Common Stock | 20,966 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-05 | Brown Kimberly | 代扣税 (F) | Common Stock | 133 | USD 76.31 | USD 10,149 | SEC 申报 ↗ |
| 2026-03-05 | Brown Kimberly | 奖励/授予 (A) | Common Stock | 6,158 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Niedzwiecki Daniel | 代扣税 (F) | Common Stock | 8,259 | USD 76.30 | USD 630,162 | SEC 申报 ↗ |
| 2026-03-02 | Niedzwiecki Daniel | 奖励/授予 (A) | Common Stock | 5,169 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Morgan Amanda Michelle | 代扣税 (F) | Common Stock | 3,336 | USD 76.30 | USD 254,537 | SEC 申报 ↗ |
| 2026-03-02 | Morgan Amanda Michelle | 奖励/授予 (A) | Common Stock | 2,782 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Marshall Robert J. Jr. | 代扣税 (F) | Common Stock | 10,652 | USD 76.30 | USD 812,748 | SEC 申报 ↗ |
| 2026-03-02 | Marshall Robert J. Jr. | 奖励/授予 (A) | Common Stock | 8,491 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LNTH |
| CIK | 0001521036 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2835 In Vitro & In Vivo Diagnostic Substances |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 485 transaction lines from 2020-02-19 to 2026-08-31 8 P purchase lines · 233 S sale lines · 244 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.